Uticaj tipa materijala za plombiranje zuba na koncentraciju interleukina 9 u uzorcima gingivalne sulkusne tečnosti

  • dr Vladimir Stefanović dr Vladimir Stefanović v.stefanovicvma@gmail.com
  • Ervin Taso Clinic for Dental Medicine, Military Medical Academy, Belgrade, Serbia
  • Aleksandra Petković Ćurčin Institute for Medical Research,Military Medical Academy, Belgrade, Serbia
  • Mirjana Djukić Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia
  • Milka Gardašević Clinic for Maxilofacial Surgery,Military Medical Academy, Belgrade, Serbia
  • Mia Rakić Institute for Biological Research “Siniša Stanković”, University of Belgrade, Belgrade, Serbia
  • Struillou Xavier Department of Periodontology, University of Nantes, Nantes, France
  • Milena Jović Institute for Pathology, Military Medical Academy, Belgrade, Serbia
  • Karolina Miller Histopathology Department, Dorset County Hospital NHS Foundation Trust, Dorchester, United Kingdom
  • Ivan Stanojević Institute for Medical Research,Military Medical Academy, Belgrade, Serbia
  • Danilo Vojvodić Institute for Medical Research,Military Medical Academy, Belgrade, Serbia
Ključne reči: dental caries||, ||zub, karijes, dental materials||, materijali za punjenje korenskog kanala, gingival cervicular fluid||, ||gingivalna sulkusna tečnost, cytokines||, ||citokini, interleukin-9.||, ||interleukin-9.,

Sažetak


Uvod/Cilj. Jedan broj citokina i limfokina (IL1ß, ENA78, IL6, TNFα, IL8 I S100A8) izlučuje se tokom upale zubne pulpe. Analiza gingivalne sulkusne tečnosti (gingival crevicular fluid – GCF) omogućava neinvazivno proučavanje opšteg odgovora pacijenta na lokalne promene u usnoj duplji. Iako nivoi GCF mogu da odražavaju stanje upale kako u zubnoj pulpi, tako i u gingivi susednog zuba, uzorci GCF zuba bez značajnijeg gingivitisa mogli bi se tumačiti kao pokazatelji procesa u pulpi. Cilj ovog istraživanja bio je da se ispitaju nivoi IL9 u GCF kod pacijenata sa zubnim karijesom i da se utvrdi eventualni uticaj različitih materijala za zubne ispune na lokalnu proizvodnju IL9. Metode. U studiju je bilo uključeno 90 pacijenata, starih od 18 do 70 godina, uz primenu kriterijuma za uključivanje/isključivanje za prospektivne kliničke studije. Od ukupno šest materijala za punjenje pripremljenih kaviteta, tri je korišćeno za privremenu i tri za trajnu ispunu. Prema težini zubnog ispuna, pacijenti su bili podeljeni na tri grupe: oni sa ispunama lakšim od 0,50 g, sa ispunama od 0,50 do 1,00 g i sa ispunama težim od 1,00 g. Uzorci su uzimani iz gingivalnog sulkusa primenom tehnike filter papira. Korišćeni klinički parametri bili su indeks krvarenja, plak indeks (Silness-Lou, 0–3), gingivalni indeks (0–3) i dubina gingivalnog sulkusa. Koncentracije citokina određene su komercijalnim citomiksom. Rezultati. Težina zubne ispune ukazivala je na tendenciju opadanja vrednosti IL9, što je značilo da je veće oštećenje zuba, sa zubnom ispunom težom od 1,00 g, praćeno nižom koncentracijom IL9 u GCF. Vrednosti IL9 bile su u korelaciji sa stepenom gingivalnog indeksa i dubinom gingivalnog sulkusa, pogotovu u poodmaklom gingivitisu i izraženijim anatomskim promenama ivica zuba. Različite ispune izazivale su različite lokalne sekrecije IL9. Cink-polikarbonatni cement i amalgamska ispuna izazvale su značajan i dugotrajan pad nivoa lokalnog IL9, dok je primena tetrik-evocerama i GMA-BISK znatno povisila nivoe IL9. Zaključak. Rezultati dobijeni u ovoj studiji ukazuju da se IL9 u GCF može koristiti kao mera za reakciju odontoblasta na veličinu karijesa. Tip zubne ispune može da promeni biološku funkciju ćelija gingive i pulpe. Rezultati ove studije, takođe, ukazuju i na to da neke vrste ispuna mogu čak da ubrzaju zarastanje rane modulacijom aktivnosti makrofaga.

Reference

McLachlan JL, Sloan AJ, Smith AJ, Landini G, Cooper PR. S100 and Cytokine Expression in Caries. Infect Immun 2004; 72(7): 4102−8.

Elsalhy M, Azizieh F, Raghupathy R. Cytokines as diagnostic markers of pulpal inflammation. Int Endod J 2013; 46(6): 573−80.

Adachi T, Nakanishi T, Yumoto H, Hirao K, Takahashi K, Mukai K, et al. Caries-related bacteria and cytokines induce CXCL10 in dental pulp. J Dent Res 2007; 86(12): 1217−22.

Artese L, Rubini C, Ferrero G, Fioroni M, Santinelli A, Piattelli A. Vascular endothelial growth factor (VEGF) expression in healthy and inflamed human dental pulps. J Endod 2002; 28(1): 20−3.

Kokkas AB, Goulas A, Varsamidis K, Mirtsou V, Tziafas D. Irre-versible but not reversible pulpitis is associated with up-regulation of tumour necrosis factor-alpha gene expression in human pulp. Int Endod J 2007; 40(3): 198−203.

Rauschenberger CR, Bailey JC, Cootauco CJ. Detection of human IL-2 in normal and inflamed dental pulps. J Endod 1997; 23(6): 366−70.

Karapanou V, Kempuraj D, Theoharides TC. Interleukin-8 Is In-creased in Gingival Crevicular Fluid from Patients with Acute Pulpitis. J Endod 2008; 34(2): 148−51.

Horst OV, Horst JA, Samudrala R, Dale BA. Caries induced cy-tokine network in the odontoblast layer of human teeth. BMC Immunol 2011; 12(1): 9.

Farges J, Keller J, Carrouel F, Durand SH, Romeas A, Bleicher F, et al. Odontoblasts in the dental pulp immune response. J Exp Zool B Mol Dev Evol B 2009; 312B(5): 425−36.

Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T, et al. TGF-beta induces IL-9 production from human Th17 cells. J Immunol 2010; 185(1): 46−54.

Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 2003; 170(7): 3461−7.

Wiener Z, Falus A, Toth S. IL-9 increases the expression of sev-eral cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. Cytokine 2004; 26(3): 122−30.

Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, et al. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Exp Hematol 1994; 22(9): 919−23.

Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang J, Nakao M, et al. Role of human interleukin-9 as a megakaryocyte potentia-tor in culture. Exp Hematol 2002; 30(12): 1373−80.

Steenwinckel V, Louahed J, Lemaire MM, Sommereyns C, Warnier G, McKenzie A, et al. IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol 2009; 182(8): 4737−43.

Yamasaki A, Saleh A, Koussih L, Muro S, Halayko AJ, Gounni AS. IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS One 2010; 5(2): e9178.

Pilette C, Ouadrhiri Y, van Snick J, Renauld JC, Staquet P, Vaerman JP, et al. IL9 inhibits oxidative burst and TNF-α release in li-popolysaccharide-stimulated human monocytes through TGF-β. J Immunol 2002; 168(8): 4103−11.

Fawaz LM, Sharif-Askari E, Hajoui O, Soussi-Gounni A, Hamid Q, Mazer BD. Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. J Allergy Clin Immunol 2007; 120(5): 1208−15.

Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, et al. IL-9 as a mediator of Th17-driven inflamma-tory disease. J Exp Med 2009; 206(8): 1653−60.

Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci USA 2009; 106(31): 12885−90.

Hültner L, Druez C, Moeller J, Uyttenhove C, Schmitt E, Rüde E, et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol 1990; 20(6): 1413−6.

Louahed J, Zhou Y, Maloy WL, Rani PU, Weiss C, Tomer Y, et al. Interleukin 9 promotes influx and local maturation of eosino-phils. Blood 2001; 97(4): 1035−42.

Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000; 96(6): 2163−71.

Wilhelm C, Stockinger B. Innate Lymphoid Cells and Type 2 (Th2) Mediated Immune Responses - Pathogenic or Beneficial. Front Immunol 2011; 2: 68.

Love RM, Jenkinson HF. Invasion of dental tubules by oral bac-teria. Crit Rev Oral Biol Med 2002; 13(2): 171−83.

Farges J, Keller J, Carrouel F, Durand SH, Romeas A, Bleicher F, et al.. Odontoblasts in the dental pulp immune response. J Exp Zool B Mol Dev Evol 2009; 312B(5): 425−36.

Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. Biphasic Regulation of NF- B Activity Underlies the Pro- and Anti-Inflammatory Actions of Nitric Oxide. J Immunol 2001; 166(6): 3873−81.

di Maio FD, Lohinai Z, d`Arcangelo C, de Fazio PE, Speranza L, de Lutiis MA, et al. Nitric Oxide Synthase in Healthy and In-flamed Human Dental Pulp. J Dent Res 2004; 83(4): 312−6.

Takahashi K, Nakanishi T, Yumoto H, Adachi T, Matsuo T. CCL20 production is induced in human dental pulp upon stimulation by Streptococcus mutans and proinflammatory cytokines. Oral Microbiol Immunol 2008; 23(4): 320−7.

Wilhelm C, Turner J, van Snick J, Stockinger B. The many lives of IL-9: a question of survival. Nat Immunol 2012; 13(7): 637−41.

Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature 2012; 484(7395): 465−72.

Yao W, Zhang Y, Jabeen R, Nguyen ET, Wilkes DS, Tepper RS, et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013; 38(2): 360−72.

Gregersen I, Skjelland M, Holm S, Holven KB, Krogh-Sørensen K, Russell D, et al. Increased Systemic and Local Interleukin 9 Le-vels in Patients with Carotid and Coronary Atherosclerosis. PLoS One 2013; 8(8): e72769.

Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, et al. Selective probiotic bacteria induce IL-10–producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell–specific intercellular adhe-sion molecule 3–grabbing nonintegrin. J Allergy Clin Immunol 2005; 115(6): 1260−7.

Hahn C, Liewehr F. Relationships between Caries Bacteria, Host Responses, and Clinical Signs and Symptoms of Pulpitis. J Endod 2007; 33(3): 213−9.

Hahn CL, Best AM, Tew JG. Cytokine induction by Streptococ-cus mutans and pulpal pathogenesis. Infect Immun 2000; 68(12): 6785−9.

Naoum S, Martin E, Ellakwa A. Long-Term Fluoride Ex-changes at Restoration Surfaces and Effects on Surface Me-chanical Properties. ISRN Dent 2013; 2013: 579039.

Riksen EA, Kalvik A, Brookes S, Hynne A, Snead ML, Lyngstadaas SP, et al. Fluoride reduces the expression of ena-mel proteins and cytokines in an ameloblast-derived cell line. Arch Oral Biol 2011; 56(4): 324−30.

Kubota K, Lee DH, Tsuchiya M, Young CS, Everett ET, Martinez-Mier EA, et al. Fluoride Induces Endoplasmic Reticulum Stress in Ameloblasts Responsible for Dental Enamel Formation. J Biol Chem 2005; 280(24): 23194−202.

Afolabi OK, Oyewo EB, Adekunle AS, Adedosu OT, Adedeji AL. Oxidative indices correlate with dyslipidemia and pro-inflammatory cytokine levels in fluoride-exposed rats. Arh Hig Rada Toksikol 2013; 64(4): 521−9.

Huang TH, Yang CC, Ding SJ, Yeng M, Kao CT, Chou MY. In-flammatory cytokines reaction elicited by root-end filling mate-rials. J Biomed Mater Res B Appl Biomater 2005; 73(1): 123−8.

Björkman L, Brokstad KA, Moen K, Jonsson R. Minor changes in serum levels of cytokines after removal of amalgam restora-tions. Toxicol Lett 2012; 211(2): 120−5.

Fayazi S, Ostad SN, Razmi H. Effect of ProRoot MTA, Port-land cement, and amalgam on the expression of fibronectin, collagen I, and TGFβ by human periodontal ligament fibrob-lasts in vitro. Indian J Dent Res 2011; 22(2): 190−4.

Filho GJ, Cintra LT, Junior DE, Watanabe S, Faria MD, Gomes AC, et al. Effects of modified Portland cement and MTA on fibroblast viability and cytokine production. Dental Press En-dod 2012; 2(2): 20−24.

Barth KA, Waterfield JD, Brunette DM. The effect of surface roughness on RAW 264. macrophage phenotype. J Biomed Mater Res A 2013; 101(9): 2679−88.

Objavljeno
2017/03/03
Broj časopisa
Rubrika
Originalni članak